DUSA Pharmaceuticals (DUSA) Reports In-Line Q2 EPS of 6c
Tweet
Share
E-mailGet Alerts DUSA Hot Sheet
Price: $57.39 +0.40%
Financial Fact:
Loss on change in fair value of warrants: -1.7M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Loss on change in fair value of warrants: -1.7M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
DUSA Pharmaceuticals (NASDAQ: DUSA) reported Q2 EPS of $0.06, in-line with the analyst estimate of $0.06. Revenue for the quarter came in at $11.7 million versus the consensus estimate of $11.85 million.
For earnings history and earnings-related data on DUSA Pharmaceuticals (DUSA) click here.
For earnings history and earnings-related data on DUSA Pharmaceuticals (DUSA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Tencent Holdings (700:HK) (TCEHY) PT Lowered to HK$625 at Benchmark to Reflect Downward Earnings Revisions
- MeiraGTx Holdings plc (MGTX) Tops Q2 EPS by 202c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
